Globus Medical designs and sells musculoskeletal implants and enabling technologies, with a deep focus on spine surgery. Its portfolio spans spinal fusion hardware, orthopedics and surgical navigation/robotics such as the Excelsius platform. Surgeons and hospitals are the primary customers, seeking implants and systems that support complex orthopedic and spinal procedures.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 598.1 | — | 75.5 | -22.6% |
| Q2 2025 | 745.3 | — | 202.8 | 100.3% |
| Q3 2025 | 769 | — | 119 | 6% |
| Q4 2025 | 826.4 | — | 140.6 | 22.9% |
| Q1 2026 | 759.9 | 27% | 124.3 | 64.7% |
| Q2 2026 | 789.6 | 5.9% | 151.6 | -25.3% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Jefferies Financial Group Inc. (JEF), Hecla Mining Company (HL), Regal Rexnord Corporation (RRX), Stifel Financial Corp. (SF), Donaldson Company, Inc. (DCI), Forgent Power Solutions, Inc. (FPS)